Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Evome Medical Technologies Inc LNDZF


Primary Symbol: V.EVMT

Evome Medical Technologies Inc. is an international medical device company, which is focused on human performance and rehabilitative solutions. The Company’s products include Biodex Rehab product, Damar Plastics product, Mio-Guard product, Simbex services, and SDP product. Its Biodex Rehab products include Isokinetic Systems, Gait Trainer, Body-Weight Supported Training, Cycles and Ergometers... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (TSXV:EVMT)

Evome Strengthens Major Creditor Relationship After the Sale of the Simbex Unit to Riddell, LOI Related to Simbex Acquisition Debt is Cancelled

GlobeNewswire April 12, 2024

Canadian Investment Regulatory Organization Trade Resumption - EVMT

Canada NewsWire April 2, 2024

Canadian Investment Regulatory Organization Trading Halt - EVMT

Canada NewsWire April 2, 2024

Evome Sells Simbex R&D Business Unit to Riddell for $4.83M in Cash; Improves Balance Sheet, Reduces Biodex Acquisition Debt

GlobeNewswire April 2, 2024

Evome Medical Technologies Punctuates Turn Around Plan with Strong Fourth Quarter Resulting in Positive Annual Adjusted EBITDA for Fiscal Year 2023

GlobeNewswire April 1, 2024

Evome Medical Engages ICP Securities Inc. for Automated Market Making Services

GlobeNewswire February 27, 2024

Evome Medical Technologies Bolsters Board of Directors with Appointment of Strategic Senior Healthcare Executives Wayne Anderson and Bill Garbarini, Appoints Kenneth Kashkin, MD, as Chairman

GlobeNewswire February 15, 2024

Evome Medical Technologies Executes Non-Binding Letter of Intent to Extend Remaining Simbex Acquisition Debt to June 2025; Increases Sales Targets by 7.5% for Biodex Distribution Contracts; Raises Biodex Product Pricing by 2% for 2024

GlobeNewswire February 8, 2024

Evome Medical Technologies Reduces Acquisition Debt, Bolsters Management Team to Support SpaceTeck Knee(TM) and Reactive Step Trainer 2024 Product Roll-Out

GlobeNewswire January 31, 2024

Opinion & Analysis (TSXV:EVMT)

No current opinion is available.

Bullboard Posts (TSXV:EVMT)

RE:RE:Investor Relations Contact?

Thanks.   I sent the email yesterday.  I will post the reply here if I get one.
Martin1979 - 3 days ago

RE:Investor Relations Contact?

This is contact info from last NR, could you post  If you received a reply,  Thanks  Mike Seckler ‎ Chief Executive...
Zibo510 - 5 days ago

Investor Relations Contact?

Has anyone been able to contact Evome? I could not find an investor relations email.  I tried their generic Info@evomemedical.com...
Martin1979 - 5 days ago

Q1 Financials in 2+ Weeks

Anonymous is taking the SP down.  No news to justify recent trading.  Are the upcoming financials not good and someone in the...
Zibo510 - 10 days ago

Naked Short Sellers = Criminals

I would not be surprised if Anonymous Traders are doing this. The Masked Bandit's  Canadian Banks Make $Billions off...
Zibo510 - 10 days ago

RE:RE:Anonymous on the buy

House Positions for C:EVMT from 20240424 to 20240424 House Bought $Val Ave ...
ANALOG GUY - 12 days ago